AMST enters its May 20 earnings event against a backdrop of sharply rising short interest, a punishing month-long price decline, and a borrow market that turned significantly more expensive — all in a span of weeks.
The short-selling story here is impossible to ignore. Short interest as a percentage of free float climbed from roughly 2.3% in mid-April to a peak above 12% in early May — a nearly six-fold increase in under three weeks — before easing back to 7% by May 15. That unwinding has been gradual: short sellers built aggressively into the stock's collapse, and the position remains meaningfully elevated. Borrow costs tell a similar story. The cost to borrow was running around 12-13% APR through April; it then tripled, peaking near 57% before retreating to 35% as of May 15. The month-on-month change is still +198%. Availability, meanwhile, tightened sharply before loosening again — hitting as low as 24% in late April (the 52-week trough) before recovering to 102% now. That recovery suggests the initial borrow squeeze has partially unwound, but the residual cost remains elevated, indicating shorts are still paying a meaningful premium to hold their positions.
The stock itself has absorbed heavy selling pressure. AMST has fallen 53% over the past month, closing at $0.82 on May 15 — down another 6.4% on the week. The ORTEX short score of 70 confirms bearish positioning is above average, though notably it has eased from a peak of 75.8 on May 4, tracking the partial retreat in short interest. The overall ORTEX combined score of 69.9 reflects a market structure tilted against the stock. Factor scores add texture: the short score ranks in just the 8th percentile of its universe — meaning 92% of stocks carry more bearish positioning, but for a micro-cap EdTech name, even a moderate absolute level of short interest carries outsized weight. The momentum pillar in ORTEX's stock scores registers near-zero, with relative strength at deeply negative readings across all time horizons.
Ownership is concentrated almost entirely in insiders and founders. The CEO holds 16.6% of shares; combined, the top handful of named individuals control well over 30%. Institutional presence is thin — Intracoastal Capital, a known small-cap specialist, built a new 98,000-share position as of May 1, the most recent notable entry. Insider activity over the past 90 days has been limited to routine director equity awards with no open-market purchases or sales, offering no additional directional signal. Historical earnings reactions have been mixed but consistently sharp: the last four prints produced single-day moves ranging from -9.3% to +8.5%, with a tendency for five-day follow-through to amplify any initial negative move — the November 2025 print fell 5.5% on day one and nearly 20% by day five.
Tomorrow's print will test whether the recent retreat in short positioning reflects genuine covering or merely a pause — and whether any operational update from Amesite can offer a credible counternarrative to a stock that has shed more than half its value in a single month.
See the live data behind this article on ORTEX.
Open AMST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
